Refining Method Development & Validation Testing for Antibody Drug Conjugate Payloads Blogs
Read article Refining Method Development & Validation Testing for Antibody Drug Conjugate Payloads

Antibody drug conjugates (ADCs) are important targeted therapies in oncology. These are complex moieties consisting of a cell-targeting antibody combined with an active payload through a chemical linker. Key Components to Monitor in PK Studies Two significant components to monitor for PK studies are the (1) intact antibody drug conjugate…

Advantages of a Global Bioanalytical Laboratory eQMS Blogs
Read article Advantages of a Global Bioanalytical Laboratory eQMS – Beyond Regulatory Compliance

KCAS Bio launched an initiative to advance its Quality System through a 21 CFR Part 11 compliant electronic Quality Management System (eQMS) to be prepared for anticipated future regulatory requirements for Good Laboratory Practice (21 CFR 58). This was driven by the proposed rule from August 2016, the FDA is…

KCAS Bio USA Upcoming Events Blogs
Read article Meet Our Experts at these Upcoming Events!

KCAS Bio is thrilled to announce our participation in several key scientific and bioanalytical events across the United States in the coming months. These conferences provide a unique platform to showcase our cutting-edge capabilities, engage with industry leaders, and explore innovative approaches to bioanalysis. From gene therapy to toxicology and…

AAPS Summer Scientific Forum July 14 - July 17

KCAS Bio is thrilled to announce our participation in the AAPS Summer Scientific Forum, taking place in Indianapolis, Indiana, from July 14 to 17, 2025. This annual event, hosted by the American Association of Pharmaceutical Scientists, is a cornerstone gathering for pharmaceutical and biopharmaceutical professionals dedicated to advancing innovation and…

BIO International Convention June 16 - June 19

KCAS Bio is excited to announce our participation in the BIO International Convention, taking place in Boston, Massachusetts, from June 16 to 19, 2025. This premier event is a global gathering of leaders and innovators in biotechnology and life sciences, fostering collaboration and driving advancements in health, agriculture, and sustainability.

ASMS May 31 - June 1

KCAS Bio is thrilled to announce our participation in the 73rd Conference on Mass Spectrometry and Allied Topics (ASMS), taking place in Baltimore, Maryland, from May 31 to June 1, 2025. This prestigious event is a cornerstone in the field of mass spectrometry, bringing together experts, innovators, and visionaries to…

PBSS Seminar Luncheon April 1 - April 1

KCAS Bio is excited to announce our participation in the inaugural PBSS Seminar Luncheon in Seattle, Washington, on April 1, 2025. This milestone event, titled “Building the Science That Builds Biotech Companies in the Pacific Northwest,” marks a new chapter in the PBSS journey and provides a platform for discussing…

PBSS Workshop: Cell Therapy Discovery and Development April 9 - April 9

KCAS Bio is thrilled to announce our participation in the PBSS Workshop: Cell Therapy Discovery and Development: Fundamentals, Strategies and Best Practices, taking place in Foster City, California, on April 9th, 2025. This dynamic event will focus on the fundamentals, strategies, and best practices driving the advancement of cell therapy,…

An Introductory Overview of PCR-Based Assays for Bioanalysis Blogs
Read article An Introductory Overview of PCR-Based Assays for Bioanalysis

Polymerase chain reaction (PCR) assays (including digital PCR and quantitative PCR) can be used to detect and measure nucleic acids such as DNA, RNA, small RNAs, and non-coding RNAs. What may be surprising is how few guidelines and whitepapers are available for bioanalytical support for regulated Bioanalysis by dPCR and…

KCAS-podcast-thumb_TCF-016 Podcasts
Listen to podcast Podcast (The Conversational Flow) Eps #16: “The Role of Flow in Drug Autoimmune Indication Research”

In episode 16 of The Conversational Flow podcast, hosts Brian Wile and Adam Cotty are joined by Allie Greenplate and Ayman Rezk to explore “The Role of Flow in Drug Autoimmune Indication Research.” The discussion delves into the surge in pharmaceutical R&D for immune and autoimmune indications, highlighting the influence of oncology…

KCAS-blog-thumb_2025_ADC1 Blogs
Read article Maximizing Efficiencies of ADC Studies: The Ultimate Guide for Leveraging LBA and LC-MS/MS Under One Roof

Antibody-drug conjugates (ADCs) have been conventionally developed for a wide range of oncological applications since the first ADC approval in 2000 by the FDA. Typically, an ADC consists of three main components: antibody, linker conjugate, and therapeutic drug (payload). The mechanism of an ADC involves the antibody binding to a specific…

KCAS-blog-thumb_2025_WRIB April 7 - April 11

KCAS Bio is proud to announce our participation in the 19th Annual Workshops on Recent Issues in Bioanalysis (WRIB), taking place from April 7th to April 11th, 2025, in New Orleans, Louisiana. As a leading event for the bioanalytical community, WRIB brings together global experts to share innovative solutions, discuss…